School of Biomedical Engineering , The Fourth Military Medical University , 169th Changle West Road , Xi'an , Shaanxi 710032 , China.
Department of Biomedical Engineering , Case Western Reserve University , 10900 Euclid Avenue , Cleveland , Ohio 44106 , United States.
Bioconjug Chem. 2019 Aug 21;30(8):2191-2200. doi: 10.1021/acs.bioconjchem.9b00429. Epub 2019 Aug 6.
X-ray excited photodynamic therapy (X-PDT), which utilizes X-rays as the energy source and X-ray luminescent nanoparticles (XLNPs) as the transducer to excite photosensitizers (PS), resolves the penetration problem of light in traditional PDT to enable the treatment of deep-seated tumors. Nevertheless, the high X-ray dosage used in X-PDT hampers its potential applications in clinics. In this study, to alleviate the dose problem, β-NaLuF:Tb spherical nanoparticles (NPs) with ultrastrong green X-ray excited optical luminescence (XEOL) due to the less nonradiative relaxation probability and high X-ray absorption mass coefficient, which perfectly matches the absorption spectrum of a photosensitizer named rose bengal (RB), were synthesized and employed as the energy transducer for X-PDT. After covalent conjugation of NPs with RB, high Förster resonant energy transfer (FRET) efficiency up to 94.29% was achieved, leading to high production of singlet oxygen. X-PDT efficacy was evaluated by nude mice with a HepG2 tumor xenograft. With excellent biocompatibility, the synthesized NPs-RB nanocomposite showed significant antitumor efficiency up to 80 ± 12.3% with a total X-ray dose of only 0.19 Gy, demonstrating the feasibility of low-dose X-PDT for the first time. The present work provides a promising platform for X-PDT in deep-seated tumors.
X 射线激发光动力疗法(X-PDT)利用 X 射线作为能量源和 X 射线发光纳米粒子(XLNPs)作为换能器来激发光敏剂(PS),解决了传统 PDT 中光的穿透问题,从而能够治疗深部肿瘤。然而,X-PDT 中使用的高剂量 X 射线阻碍了其在临床中的潜在应用。在这项研究中,为了缓解剂量问题,我们合成了具有超强绿色 X 射线激发光致发光(XEOL)的β-NaLuF:Tb 球形纳米粒子(NPs),由于非辐射弛豫概率较低和高 X 射线吸收质量系数,完美匹配了名为玫瑰红(RB)的光敏剂的吸收光谱,被用作 X-PDT 的能量换能器。NPs 与 RB 共价偶联后,实现了高达 94.29%的高Förster 共振能量转移(FRET)效率,导致单线态氧的大量产生。通过裸鼠的 HepG2 肿瘤异种移植实验评估了 X-PDT 的疗效。合成的 NPs-RB 纳米复合材料具有优异的生物相容性,在总 X 射线剂量仅为 0.19Gy 的情况下,显示出高达 80±12.3%的显著抗肿瘤效率,首次证明了低剂量 X-PDT 的可行性。本工作为深部肿瘤的 X-PDT 提供了一个有前途的平台。